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Abstract
Purpose—Both substance use and depression are common in adolescence and often comorbid. 
Past research has produced conflicting results on whether there is a temporal relationship and if so, 
in which direction it operates and how it may vary by sex. The purpose of this paper is to explore 
the longitudinal, potentially bidirectional, relationships between high-frequency substance use and 
depressive symptoms from adolescence into young adulthood for males and females.
Methods—Using data from the National Longitudinal Study of Adolescent to Adult Health we 
investigated longitudinal associations between high frequency substance use (alcohol, cigarettes, 
and marijuana) and depressive symptoms. The linear mixed effects models were stratified by sex 
and used a lagged measure of the dependent variable to test temporal relationships. A random 
intercept was used for respondent ID.
Results—Increases in depressive symptoms were significantly associated with a later increase of 
about a half day in marijuana use frequency for males and nearly a two day increase in smoking 
frequency for females. Conversely, increases in smoking frequency were significantly associated 
with approximately a 0.6-point increase for females and 0.4-point increase for males in depressive 
symptoms at a later wave.
Conclusions—Results indicate a bidirectional relationship between smoking and depressive 
symptoms for females. For males, there was evidence supporting self-medication with marijuana 
and for smoking being associated with later increases in depressive symptoms. Results inform how 
substance use and depression screening, prevention and treatment efforts should be paired and 
targeted for males and females.
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1. Introduction
Substance use and depression are common in adolescence, frequently co-morbid, and have 
serious short- and long-term health implications (Chassin, Hussong, & Beltran, 2009; 
Fletcher, 2010; Kann, Kinchen, Shanklin, & et al., 2014). Despite substantial research, the 
directionality between the two, and whether directionality varies by sex, remains unclear. 
The self-medication hypothesis asserts that risk taking is used to ameliorate depressive 
symptoms possibly through lowering impulse control or motivation (Chassin et al., 2009; 
Khantzian, 1997). Several studies support this pathway. For example, one study followed 
over 4,000 adolescents from grades 9 to 12 and found those reporting higher depressive 
symptoms in grade 9 reported faster increases in cigarette and marijuana use (Hooshmand, 
Willoughby, & Good, 2012). Burns et al. followed a small group of rural adolescents for two 
years and found baseline depression scores were associated with later tobacco use (Burns et 
al., 2004). Below we illustrate the mixed findings from research in this area, focusing on 
papers using advanced longitudinal methods.
Sex complicates the self-medication hypothesis as adolescent females generally report more 
depression and less risk taking; the aforementioned studies did not examine sex differences 
(Chassin et al., 2009; Kann et al., 2014). Studies examining sex differences show conflicting 
results. For example, symptoms of depression were positively associated with alcohol, 
tobacco, and drug use in a clinical sample of 400 youths but relationships were not 
moderated by sex (Schwinn, Schinke, & Trent, 2012). In contrast, in a sample of ninth and 
10th grade students, overall negative mood predicted rapid smoking escalation in boys, but 
only those with affect-related motives for smoking; for girls, negative mood variability 
predicted smoking escalations indicating moderation by sex (Weinstein & Mermelstein, 
2013). Another study that followed students through high school found an increase in 
depressive symptoms predicted trying smoking for boys but not for girls (Killen et al., 
1997). Similarly, with a sample of over 600 African American adolescents who were 
interviewed annually for six years starting in high school, depressive symptoms predicted 
marijuana use in males but not in females (Repetto, Zimmerman, & Caldwell, 2008). 
However, a small study of 200 undergraduate women found support for self-medication with 
alcohol (Mushquash et al., 2013).
Some sex differences in self-medication could be due to differences in the substances. A 
study of cannabis-dependent respondents found cannabis increased depressive symptoms 
among those with a history of depression though it improved control of aggression, which is 
more common among males (Arendt et al., 2007; B. Green & Ritter, 2000; Zahn-Waxler, 
Shirtcliff, & Marceau, 2008). This may explain findings supporting male’ self-medication 
with marijuana (Henry et al., 1993; Repetto et al., 2008; Schuster, Mermelstein, & 
Wakschlag, 2013). The Nicotine Dependence in Teens study revealed cigarette smoking 
does not seem to reduce depressive symptoms but can slow rate of change over time 
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(Chaiton, Cohen, O’Loughlin, & Rehm, 2010). As depressive symptoms can be less gender-
normative for males, they may have stronger motivations than females to self-medicate and 
slow symptom progression (Evans, Frank, Oliffe, & Gregory, 2011; Tamres, Janicki, & 
Helgeson, 2002). Finally, in a sample of 400 eighth grade students, Tomlinson and Brown 
(2012) found depressive symptoms did predict heavier, more frequent, and solitary drinking 
but the relationship may be moderated by social anxiety and alcohol expectancies, which 
may vary by sex (Tomlinson & Brown, 2012).
Alternatively, there is support for the reverse pathway that substance use leads to depression, 
though results are again mixed. Using data from Waves I and II of Add Health, one study 
found both sexual risk taking and substance use predicted an increased likelihood of future 
depression; the self-medication pathway was not supported in their analyses (Hallfors, 
Waller, Bauer, Ford, & Halpern, 2005). Similarly another study using Add Health data from 
Waves I and II, found no relationship between depression and later smoking but did find 
support for the reverse (Goodman & Capitman, 2000). Longitudinal analyses for over 1,000 
New Zealand youth indicated the best-fitting causal model was from alcohol abuse or 
dependence to depression, though they tested both directions (Fergusson, Boden, & 
Horwood, 2009). A longitudinal study of African Americans from age 6 to 42 found 
increased substance use (alcohol, marijuana, cocaine) in adolescence predicted 
psychological distress in young adulthood but only for men (Green, Zebrak, Robertson, 
Fothergill, & Ensminger, 2012). These latter findings conflict with other theoretical and 
empirical findings indicating females are more vulnerable to increased depression resulting 
from substance use, perhaps due to their greater interpersonal sensitivity and vulnerability to 
interpersonal stress (Ge, Lorenz, Conger, & et. al, 1994; Hallfors et al., 2005; Rudolph, 
2002).
Previous studies of the association between depression and substance use in adolescents are 
limited by cross-sectional design or, when longitudinal, by using non-representative 
samples, short time periods, or not examining both directions or sex differences (Brook, 
Brook, Zhang, Cohen, & Whiteman, 2002; Chinet et al., 2006). This paper prospectively 
examines directionality over a longer time period using the population-based Add Health 
sample and stratifying by sex. Based on prior research, we hypothesized greater support for 




Add Health is a school-based longitudinal study that includes a nationally representative 
U.S. sample of adolescents who were in grades 7-12 in the 1994-95 school year (Wave I). 
There have been four in-home interview waves since. The analysis sample is restricted to 
respondents subsequently interviewed at ages 18 to 26 (Waves III, 2001) and ages 24 to 32 
(Wave IV, 2007-2009), with valid sampling weights (N=12,288) and who had complete data 
on all variables of interest (N=12,017, missing 2.2%). Data from Wave II were not used as 
Wave I seniors were not followed by design. Details of the Add Health study and design are 
described elsewhere (Harris, 2013). All Add Health processes were approved by the 
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Institutional Review Board at the University of North Carolina, Chapel Hill, these analyses 
were deemed exempt.
2.2 Measures
2.2.1 Depression—We used the nine items from the Center for Epidemiologic Studies 
Depression scale (CES-D) that appeared at each interview wave, as prior Add Health studies 
have done (alpha=0.8). The psychometrics of a seven-item CES-D have been previously 
validated (Levine, 2013). Questions ask about frequency of symptoms in the past week, 
though 12-month re-test reliability is high (Eaton, Muntaner, Smith, Tien, & Ybarra, 2004). 
Answers are scored from 0 to 3, indicating rarely to most of the time; the summed score 
ranges from 0 to 27. The CES-D captures depressive symptoms but is not a diagnostic tool 
(Eaton et al., 2004).
2.2.2 Substance use—Substances include alcohol (binge drinking), cigarettes, and 
marijuana. In Add Health, substance use is assessed with either continuous or ordinal 
variables, and the time frame varies. For cigarette smoking, respondents are asked, at all 
waves, how many days they smoked in the past thirty days. At Waves I and III, the question 
is very similar for marijuana use but captures instances of use in the past 30 days (e.g., 0 to 
>900). At Wave IV, the question changes to measure how many days respondents used 
marijuana in the past thirty using a 0 to 6 ordinal scale for none to nearly every day or every 
day. Finally, binge drinking was assessed for the past year using the same ordinal variable 
(Harris, 2013). To make the measures of marijuana use frequency comparable across the 
waves, days of marijuana use was derived from the measures at Waves I and III and then 
these frequencies were made ordinal to align with the measure of marijuana use at Wave IV. 
We modeled each substance individually controlling for use of the others.
2.2.3 Controls—Substance use and depressive symptoms can vary along 
sociodemographic lines so covariates were included for respondent’s self-identified race/
ethnicity (Hispanic and non-Hispanic White, Black, Asian, Native American, and Other) and 
educational attainment of both the parents and the respondent (less than high school, high 
school graduate, some college, or college graduate or higher) as a proxy for socioeconomic 
status (Chassin et al., 2009). Respondent’s age was also included as substance use can vary 
substantially by age and the age ranges are fairly wide within waves.
2.3 Analysis
Linear mixed effects models with lagged measures of the dependent variable were used to 
evaluate both the Self-Medication and reverse pathways. Mixed effects models control for 
time invariant unobserved characteristics, reducing vulnerability to endogeneity, and are 
fairly robust to violations of normality (Fitzmaurice, Laird, & Ware, 2011). Also, the 
inclusion of a prior measure of the dependent variable in the models will effectively test the 
relationship between an earlier measure of the predictor variable and a later change in the 
dependent variable. In the models, the CES-D score was scaled by 5 so the regression results 
display a substantively meaningful change. For the figures displaying predicted changes in 
substance use frequency or depressive symptoms for each sex, race was set to White, 
parental education and respondent education were held at the referent value (college 
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graduation or higher), and all other covariates were held at their means. We used the 
original, rather than the scaled, CES-D to ease interpretability in the figures. All analyses 
were stratified by sex and used longitudinal weights to adjust for unequal probability of 
selection into the sample and nonresponse over time. Additionally, we adjusted variance 
estimates for clustering at the primary sampling unit and stratification by region. We used 
Stata, version 13.0 (Stata Corp, College Station TX, 2013). We test our assumptions of 
linearity in the ordinal substance use measures by treating the variables as ordinal and 
continuous in two different models and comparing the BIC between the two models. We also 
test our assumption that the strengths of the association from Wave I to Wave III will be 
equivalent to the association between Wave III and Wave IV with an interaction term 
between a Wave IV indicator variable and the key predictors.
3. Results
Table 1 outlines the analysis sample’s demographic characteristics. Across all waves, the 
mean CES-D score was approximately one point higher for females than males (p<0.001). 
Males consistently reported more substance use than females, except for cigarette smoking 
at Wave I.
Table 2 shows the results of the three linear mixed effects models with frequency of each 
substance rotating as the dependent variable to test the self-medication pathway, CES-D was 
the independent variable. The intercept of this model was allowed to vary randomly by 
respondent ID. The results indicate that for males, a 5-point increase in depressive 
symptoms was associated with a 0.08 (p<0.01) later increase in marijuana use frequency. For 
females, a 5-point increase in depressive symptoms was associated with a 0.31 (p<0.05) later 
increase in cigarette smoking frequency. Also, the standard deviation of the intercept 
indicates meaningful variation in the intercept by respondent ID.
Using the results from Table 2, the predicted mean marijuana use frequency (for males) and 
smoking frequency (for females) as depressive symptoms increase are displayed in Figures 1 
and 2 below, respectively. A maximum increase on the CES-D is predicted to increase male 
mean monthly marijuana use frequency from approximately 0.5 to 1, or one day of 
marijuana use in the past month. For females, a maximum increase in depressive symptoms 
is predicted to increase mean monthly smoking frequency by nearly 2 days.
Table 3 shows the results of the linear mixed effects models testing the relationship between 
substance use frequency and later depressive symptoms. The intercept of this model was 
allowed to vary randomly by respondent ID. The results indicate a 5-day increase in 
smoking frequency was associated with a 0.02 (p<0.01) increase for males and a 0.05 
(p<0.001) increase for females in later depressive symptoms. The standard deviation of the 
intercept indicates some variation in the intercept by respondent ID. Further, the linearity 
assumption for the ordinal substance use measures was supported as the BIC estimates from 
models with the measures coded as continuous and then categorical were very similar. The 
assumption that the strengths of associations between the waves would be equivalent was 
partially supported as the interactions between the Wave IV indicator variable and the 
substance use predictors were not statistically significant. But, the interactions between the 
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Wave IV indicator variable and the depressive symptoms predictors in the marijuana self-
medication model for males and the cigarette self-medication model for females were both 
statistically significant.
Figure 3 shows the predicted mean CES-D score as smoking frequency increases for males 
and females. For a 30-day increase in smoking frequency, there was a predicted nearly 0.4 
point increase in the mean CES-D score for males and a 0.6 point increase for females.
4. Discussion
We assessed the relationship directionality between depressive symptoms and high 
frequency substance use from adolescence into young adulthood using a nationally 
representative sample. Overall, we found support for each pathway. Depressive symptoms 
were associated with increases in later smoking frequency for females and marijuana use 
frequency for males, consistent with the self-medication hypothesis though contrary to our 
hypothesis of a stronger relationship for males (Khantzian, 1997). Smoking frequency was 
also associated with later increases in depressive symptoms for both males and females, and 
the relationship was stronger for females, consistent with our hypothesis.
Our most robust finding is that an increase in depressive symptoms among females is 
significantly associated with a nearly two-day later increase in monthly smoking frequency. 
Evidence of depression self-medication with cigarette smoking has been found elsewhere, 
perhaps because cigarettes have been linked with increases in positive affect and decreases 
in negative affect, both of which are implicated in depression (Audrain-Mcgovern, 
Rodriguez, & Leventhal, 2015; Burns et al., 2004; Hedeker, Mermelstein, Berbaum, & 
Campbell, 2009; Hooshmand et al., 2012). However, our finding of self-medication with 
cigarettes only among females contrasts with prior longitudinal analyses. Two analyses of 
high school students, one sample followed for 15 months and the other for four years, found 
increases in depressive symptoms predicted smoking initiation and escalation only for males 
(Killen et al., 1997; Weinstein & Mermelstein, 2013). Another analysis, using Add Health 
data from Waves I and III, found females with high depressive symptoms were less 
vulnerable to subsequent increases in cigarette use (Needham, 2007). One potential 
explanation for our finding is our use of a longer developmental timespan than previous 
studies—from adolescence into young adulthood— allowed for a more complete picture. 
Also, there is empirical support for why these associations may be stronger for females. A 
longitudinal survey of adolescents found both low positive affect and high negative affect 
increased the risk of smoking for females and only high negative affect increased risk for 
males; this suggests females have a stronger impulse to self-medicate (Audrain-Mcgovern et 
al., 2015).
We also found support for males self-medicating depressive symptoms, though with 
marijuana instead of cigarettes. The size of the association was smaller; an increase in 
depressive symptoms was associated with approximately a half-day increase in monthly use 
frequency. This result has been found previously but is somewhat perplexing as other studies 
have found marijuana use may aggravate rather than soothe depressive symptoms (Arendt et 
al., 2007; Green & Ritter, 2000). One possible explanation is that males are not self-
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medicating depression but aggression, for which marijuana appears effective (Arendt et al., 
2007). Aggression may be comorbid with depression in males as they are more likely to be 
antagonistic and anti-social when depressed compared to females (Nolen-Hoeksema, 1990; 
Zahn-Waxler et al., 2008). Alternatively, depressive symptoms can predict delinquency in 
males and marijuana may be appealing for this as an illicit substance (Schuster et al., 2013). 
Finally, although a half-day increase in marijuana use frequency may not seem clinically 
relevant, it should be noted that the association reflects a time span of approximately seven 
years; past studies with shorter time spans have found larger effect sizes (Henry et al., 1993; 
Repetto et al., 2008; Schuster et al., 2013).
Despite the contention that men are more likely to cope by drinking alcohol, we found no 
support for males self-medicating with binge drinking (Nolen-Hoeksema, 2012). This may 
be a function of our measure of alcohol use. Binge drinking in adolescence and early 
adulthood is relatively common and generally a social activity. Past studies have found 
associations between solitary drinking and depression (Hooshmand et al., 2012; Needham, 
2007; Tomlinson & Brown, 2012). Alternatively, if males do self-medicate depression with 
delinquent behavior, alcohol may be less appealing as the most prevalent form of substance 
use (Hooshmand et al., 2012; Schuster et al., 2013).
Regarding the reverse pathway, we do find that an increase in smoking frequency is 
significantly associated with modest later increases in depressive symptoms among both 
males and females. Our findings are stronger for females, in line with prior analyses and our 
hypotheses (Ge et al., 1994; Hallfors et al., 2005; Rudolph, 2002). Two previous similar 
studies found smoking associated with a 200% later increase in the odds of depression 
(Goodman & Capitman, 2000; Hallfors et al., 2005). There are three important differences 
between these studies and our own that may contribute to differences in the strength of the 
association. First, the earlier studies examined a one-year timespan, compared to our seven 
year span. Second, they treated depression as a binary rather than using frequency of 
symptoms; the latter relationship is likely more subtle. Third, one of these earlier studies 
used clusters of risk behaviors and found the strong association between cigarette smoking 
and later depression when smoking was combined with sexual risk behavior, suggesting 
combinations of risk behaviors are more potent predictors of depressive symptoms (Hallfors 
et al., 2005).
Taken together, our findings suggest a bidirectional relationship between depressive 
symptoms and cigarette smoking for females. This could be interpreted as evidence that self-
medication of depressive symptoms with nicotine does not ameliorate the symptoms 
(Chaiton et al., 2010). Further, as females increase their cigarette smoking frequency, they 
are engaging in a non-normative activity that could increase interpersonal stress, thereby 
increasing depressive symptoms (Ge et al., 1994; Nelson et al., 2008; Rudolph, 2002). Past 
studies that tested for bidirectional associations using Add Health data (Goodman & 
Capitman, 2000; Hallfors et al., 2005) and a sample of Canadian adolescents (Hooshmand et 
al., 2012) did not find them. However, they used different measures of smoking and different 
time frames and one explained the bidirectional association away with potential 
confounders.
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Our findings should be considered in the context of this study’s limitations. Limitations 
include assumptions of linearity in the measures of use frequency for marijuana and binge 
drinking, and that the strengths of the associations between high frequency substance use 
and depressive symptoms are equivalent from Wave I to Wave III and from Wave III to Wave 
IV. However, we tested both assumptions and they were partially supported, though there 
appears to be variation by wave in the self-medication pathways for both males and females, 
something future research could examine. Third, the use of lagged measures of the 
dependent variable could introduce bias that would decrease the magnitude of the 
associations, though Monte Carlo simulations reveal their use is acceptable when we expect 
prior conditions will influence the current process. Further, if the sample is larger than 50, 
the bias is small and the chance of making incorrect inferences is less than 1% (Keele & 
Kelly, 2006). A fourth consideration is that the magnitude of identified associations, 
especially for smoking predicting later increases in depressive symptoms, is small. However, 
as seven years separate each of the interview waves and we are using continuous measures 
of depressive symptoms, this is not surprising. Fifth, though the prevalence of adolescent 
substance use has changed since 1994 when the first wave of data were collected, we have 
no reason to suspect the relationship between substance use and depression has changed. 
Finally, our results may be influenced by the bidirectional relationship between depression 
and substance use. To investigate this, we ran all models with only the youngest respondents 
at Wave I as they had a very low prevalence of substance use, and found similar results 
(available upon request).
Present findings support the self-medication hypothesis, but also indicate it is not the only 
explanation. We find support for males and females self-medicating depressive symptoms 
with marijuana and cigarettes, respectively, though we also find cigarette smoking 
significantly associated with later increases in depressive symptoms. Future research is 
needed to understand potential mediators of this pathway. In the meantime, study results can 
inform adolescent health care. The United States Preventive Services Task Force recently 
supported depression screening for adolescents and the Affordable Care Act supports 
substance use screening for adolescents (U.S. Department of Health and Human Services, 
2012; Williams, O’Connor, Eder, & Whitlock, 2009). This research reveals screening for 
both is important and, where resources are limited, females screening positive for either 
smoking or depression should be targeted for both. For males, those screening positive for 
depression should also be targeted for marijuana use prevention and those screening positive 
for smoking should be screened for depression.
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• Depressive symptoms associated with later increases in smoking for females
• Depressive symptoms associated with later increases in marijuana for males
• Smoking linked with later increases in depressive symptoms, especially in 
females
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Figure 1. Predicted change in marijuana use frequency as depressive symptoms increase, Malesa
a The figure shows results from the same model as outlined in Table 2, but the horizontal 
axis was changed to the unscaled measure of depressive symptoms to maximize 
interpretability.
Wilkinson et al. Page 13













Figure 2. Predicted change in cigarette smoking frequency as depressive symptoms increase, 
Femalesa
a The figure shows results from the same model as outlined in Table 2, but the horizontal 
axis was changed to the unscaled measure of depressive symptoms to maximize 
interpretability
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Figure 3. Predicted change in depressive symptoms as smoking frequency increasesa
a The figure shows results from the same model as outlined in Table 3, but the vertical axis 
was changed to the unscaled measure of depressive symptoms to maximize interpretability.
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Table 1







 Hispanic 886 (12.2) 967 (11.4)
 Black 1014 (14.9) 1482 (16.0)
 Asian 412 (3.8) 397 (3.4)
 Native American 111 (2.3) 113 (1.8)
 Other 50 (1.0) 54 (1.0)
 White 2970 (65.8) 3507 (66.5)
Parental Education
 Less than high school 630 (11.9) 843 (11.5)
 High school graduate 1318 (26.1) 1680 (28.2)
 Some college 1603 (30.0) 1845 (28.7)
 College graduate or higher 1892 (32.1) 2152 (31.6)
Respondent Education (Wave IV)
 Less than high school 458 (9.3) 377 (6.9)
 High school graduate 1007 (20.8) 837 (13.4)
 Some college 2361 (41.6) 2872 (44.2)




 Wave I 15.5 (0.12) 15.3 (0.12)
 Wave III 21.9 (0.12) 21.7 (0.12)
 Wave IV 28.4 (0.12) 28.2 (0.12)
CES-D (mean (SE))
c
 Wave I 5.1 (0.09) 6.3 (0.12)***
 Wave III 4.0 (0.07) 4.9 (0.09)***
 Wave IV 4.8 (0.09) 5.6 (0.09)***
Binge Drinking (mean (SE))
 Wave I 0.8 (0.05) 0.5 (0.03)***
 Wave III 1.7 (0.06) 0.9 (0.04)***
 Wave IV 1.5 (0.04) 0.9 (0.04)***
Cigarettes (mean (SE))
 Wave I 4.3 (0.31) 4.7 (0.37)
 Wave III 9.4 (0.32) 8.3 (0.42)**
 Wave IV 9.6 (0.34) 7.7 (0.40)***
Marijuana Use (mean (SE))
 Wave I 0.5 (0.04) 0.4 (0.03)**
 Wave III 1.1 (0.05) 0.6 (0.04)***


















 Wave IV 0.9 (0.04) 0.4 (0.03)***
*p<0.05;
a




The sex differences in the means of the key measures were tested and stars (*) were used to indicate if the mean for females was significantly 
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Table 2
Linear mixed effects models of the relationship between depressive symptoms at an earlier wave and substance 
use frequency at a later wave, Males and Females
















CES-D −0.01 0.24 0.08** 0.00 0.31* 0.03
(0.03) (0.22) (0.03) (0.02) (0.15) (0.02)
Binge drinking 1.24*** 0.25*** 1.69*** 0.27***
(0.14) (0.02) (0.18) (0.02)
Cigarettes 0.03*** 0.04*** 0.02*** 0.03***
(0.00) (0.00) (0.00) (0.00)
Marijuana 0.23*** 1.78*** 0.27*** 2.11***
(0.02) (0.13) (0.02) (0.14)
Age 0.10*** 0.61*** 0.02*** 0.03*** 0.59*** 0.00
(0.01) (0.05) (0.01) (0.00) (0.03) (0.00)
Race/ethnicity
Hispanic −0.11 −2.68*** 0.22* −0.04 −3.13*** 0.10*
(0.07) (0.52) (0.10) (0.05) (0.44) (0.04)
 Black −0.49*** −3.61*** 0.32*** −0.28*** −4.77*** 0.14***
(0.06) (0.36) (0.05) (0.03) (0.26) (0.03)
 Asian −0.49*** −0.99 0.00 −0.21*** −2.15*** 0.06
(0.06) (0.51) (0.07) (0.05) (0.45) (0.05)
 Native American −0.15 0.67 0.25 −0.03 −0.22 0.16
(0.14) (1.03) (0.14) (0.09) (1.11) (0.10)
 Other 0.12 −2.53* 0.22 −0.45*** 0.06 0.26
(0.21) (1.26) (0.20) (0.12) (1.38) (0.18)
 White (referent) (referent) (referent) (referent) (referent) (referent)
Parental education
 < High school −0.06 −0.80 −0.18 −0.04 0.58 −0.19***
(0.09) (0.70) (0.11) (0.05) (0.49) (0.05)
 High school 0.08 0.66 −0.26*** −0.03 1.74*** −0.17***
(0.07) (0.55) (0.07) (0.04) (0.40) (0.04)
 < College 0.01 0.06 −0.12 0.05 0.55 −0.07
(0.05) (0.45) (0.06) (0.04) (0.34) (0.04)
 College or higher (referent) (referent) (referent) (referent) (referent) (referent)
Respondent education
 < High school −0.32*** 6.99*** 0.26** −0.17* 7.44*** 0.15*
(0.09) (0.74) (0.09) (0.07) (0.63) (0.07)
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 High school −0.38*** 5.14*** 0.13 −0.30*** 4.37*** 0.08
(0.08) (0.61) (0.09) (0.05) (0.42) (0.05)
 < College −0.33*** 4.31*** 0.12* −0.26*** 4.08*** 0.02
(0.07) (0.42) (0.06) (0.04) (0.34) (0.04)
 College or higher (referent) (referent) (referent) (referent) (referent) (referent)
Constant −1.16*** −14.51*** −0.52*** −0.02 −13.78*** −0.01




Respondent ID 0.15 28.0 0.29 0.06 24.80 0.16
(0.04) (2.27) (0.05) (0.02) (2.06) (0.03)
Residual 1.95 79.83 1.95 1.14 68.55 1.05








When the slope was allowed to randomly vary by age, there was not meaningful variation and so the final models only allow for random 
intercepts.
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Table 3
Linear mixed effects models of the relationship between substance use frequency at an earlier wave and 

















 Black 0.15*** 0.20***
(0.03) (0.03)
 Asian 0.25*** 0.30***
(0.04) (0.05)
 Native American 0.09 0.07
(0.07) (0.08)
 Other 0.00 −0.04
(0.17) (0.11)
 White (referent) (referent)
Parental education
 < High school 0.20*** 0.18***
(0.05) (0.04)
 High school 0.07* 0.11***
(0.03) (0.03)
 < College 0.02 0.09**
(0.03) (0.03)
 College or higher (referent) (referent)
Respondent education
 < High school 0.16*** 0.45***
(0.05) (0.05)
 High school 0.08* 0.27***
(0.03) (0.04)
 < College −0.02 0.11***
(0.03) (0.02)
 College or higher (referent) (referent)
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